(TEAM HEALTH LOGO)

                                                       Media Contact:
FOR IMMEDIATE RELEASE                                  John Lovallo
                                                       Ogilvy Public Relations
                                                       212-880-5216
                                                       john.lovallo@ogilvypr.com

        TEAM HEALTH, INC. COMMENCES TENDER OFFER AND CONSENT SOLICITATION

         KNOXVILLE, Tenn., February 25, 2004 - Team Health, Inc. (the "Company")
announced today that it has commenced a cash tender offer and consent
solicitation (the "Offer") for any and all of its $100.0 million aggregate
principal amount of 12% Senior Subordinated Notes due 2009 (CUSIP No. 87815VAC7)
(the "Notes").

         The Offer is scheduled to expire at 12:00 midnight, New York City time,
on Monday, March 22, 2004, unless extended or earlier terminated (the
"Expiration Date"). The consent solicitation will expire at 5:00 p.m., New York
City time, on Monday, March 8, 2004 (the "Consent Date"). Holders tendering
their Notes will be required to consent to certain proposed amendments to the
indenture governing the Notes, which will eliminate substantially all of the
restrictive covenants. Holders may not tender their Notes without delivering
consents or deliver consents without tendering their Notes.

         Holders who validly tender their notes by the Consent Date will receive
the total consideration of $1,082.50 per $1,000 principal amount of Notes (if
such notes are accepted for purchase). Holders who validly tender their Notes
after the Consent Date and prior to the Expiration Date will receive as payment
for the Notes $1,062.50 per $1,000 principal amount of Notes (if such notes are
accepted for purchase). In either case, Holders who validly tender their Notes
also will be paid accrued and unpaid interest up to, but not including, the date
of payment for the Notes (if such notes are accepted for purchase).

         In addition to the Offer, the Company intends to (i) consummate a
private offering of a new series of senior subordinated notes, (ii) enter into
new senior secured credit facilities, (iii) redeem its outstanding preferred
stock and (iv) pay a dividend to holders of the Company's common stock (if
approved by the Company's board of directors). We refer to these transactions,
collectively, as the "Refinancing Transactions".

         The Offer is subject to the satisfaction of certain conditions,
including the Company's receipt of tenders of Notes representing a majority of
the principal amount of the Notes outstanding and the consummation of the
Refinancing Transactions, and is expected to be financed by a combination of the
new senior subordinated notes and borrowings under the new credit facilities.
The Company currently plans to call for redemption, upon the closing of the new
senior subordinated notes offering and the new credit facilities, in accordance
with the terms of the indenture governing the Notes, all Notes that remain
outstanding. The terms of the Offer are described in the Company's Offer to
Purchase and Consent Solicitation Statement dated February 24, 2004, copies of
which may be obtained from Georgeson Shareholder Communications.

         The Company has engaged J.P. Morgan Securities Inc. and Banc of America
Securities LLC to act as dealer managers and solicitation agents in connection
with the Offer. Questions regarding the Offer may be directed to J.P. Morgan
Securities Inc., Chad Joplin, at (212) 270-1171 (collect) and Banc of America
Securities LLC, High Yield Special Products, at (888)-292-0070 (toll-free) and
(212)-847-5834 (collect). Requests for documentation may be directed to
Georgeson Shareholder Communications, the information agent for the Offer, at
(866) 399-8793 (toll-free) and (212) 440-9800.

         The announcement is not an offer to purchase, a solicitation of an
offer to purchase or a solicitation of consent with respect to any securities.
The Offer is being made solely by the Offer to Purchase and Consent Solicitation
Statement dated February 24, 2004.

         The Company will be issuing the new senior subordinated notes in a
transaction that will not be and has not been registered under the Securities
Act of 1933, as amended, or any state securities laws and the new notes may not
be offered or sold in the United States absent registration or an applicable
exemption from the registration requirements of the Securities Act and
applicable state securities laws. This press release does not constitute an
offer to sell or the solicitation of an offer to buy any security.


                                       -2-